IMMUTEP Ltd (PRRUF)
PRRUF is quoted over the counter, not listed on an exchange. IMMUTEP Ltd files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | PRRUF, quoted over the counter |
| SEC CIK | 0001506184 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | Sydney,, Australia |
| Incorporated in | Australia |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 20-F 2026-10-23 |
| Cash and burn | 63.7M AUD cash; operating cash flow -13.9M AUD a quarter. | Report 2026-06-30 |
| Shares outstanding | 7,368,607 (2026-06-30); 7,301,948 a year earlier; 5,936,531 three years earlier. 1y figure adjusted for splits (1-for-20 overall); 3y figure adjusted for splits (1-for-20 overall). | Cover page 2026-06-30 |
| Reverse splits, 3 years | 1; latest 1-for-20 on 2026-09-28 | Source 2026-09-28 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers, Sydney, Australia | PCAOB Form AP 2026-11-05 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2026 2026-06-30 | 24.2M AUD | -79.3M AUD | -55.5M AUD | 63.7M AUD | No debt tags | 24.2M AUD | 20-F 2026-10-23 |
| FY 2025 2025-06-30 | 10.3M AUD | -61.4M AUD | -62.0M AUD | 67.4M AUD | No debt tags | 10.3M AUD | 20-F 2025-10-24 |
| FY 2024 2024-06-30 | 7.8M AUD | -42.7M AUD | -34.8M AUD | 161.8M AUD | No debt tags | 7.8M AUD | 20-F 2025-10-24 |
| FY 2023 2023-06-30 | 5.2M AUD | -39.9M AUD | -35.4M AUD | 123.4M AUD | No debt tags | 5.2M AUD | 20-F 2025-10-24 |
| FY 2022 2022-06-30 | 6.8M AUD | -32.2M AUD | -30.2M AUD | 80.0M AUD | No debt tags | 6.8M AUD | 20-F 2024-10-22 |
| FY 2021 2021-06-30 | 4.0M AUD | -29.9M AUD | -17.6M AUD | 60.6M AUD | No debt tags | 4.0M AUD | 20-F 2023-10-24 |
| FY 2020 2020-06-30 | 16.5M AUD | -13.5M AUD | -10.8M AUD | 26.3M AUD | No debt tags | 16.5M AUD | 20-F 2022-10-31 |
| FY 2019 2019-06-30 | 7.5M AUD | -18.3M AUD | -15.3M AUD | 16.6M AUD | No debt tags | 7.5M AUD | 20-F 2021-10-25 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in AUD.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | F-3 | 2023-04-28 |
| Latest annual report | 20-F | 2026-10-23 |
| Latest quarterly / interim | 6-K | 2026-11-10 |
Source: SEC EDGAR submissions feed, 740 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier